145 related articles for article (PubMed ID: 10099084)
1. Acute renal failure and intravenous immune globulin: sucrose nephropathy in disguise?
Perazella MA; Cayco AV
Am J Ther; 1998 Nov; 5(6):399-403. PubMed ID: 10099084
[TBL] [Abstract][Full Text] [Related]
2. Acute renal failure after large doses of intravenous immune globulin.
Haskin JA; Warner DJ; Blank DU
Ann Pharmacother; 1999; 33(7-8):800-3. PubMed ID: 10466908
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin-associated acute renal failure: case series and literature review.
Itkin YM; Trujillo TC
Pharmacotherapy; 2005 Jun; 25(6):886-92. PubMed ID: 15927908
[TBL] [Abstract][Full Text] [Related]
4. Acute renal failure and intravenous immune globulin: occurs with sucrose-stabilized, but not with D-sorbitol-stabilized, formulation.
Chapman SA; Gilkerson KL; Davin TD; Pritzker MR
Ann Pharmacother; 2004 Dec; 38(12):2059-67. PubMed ID: 15536143
[TBL] [Abstract][Full Text] [Related]
5. Renal insufficiency after intravenous immune globulin therapy: a report of two cases and an analysis of the literature.
Cayco AV; Perazella MA; Hayslett JP
J Am Soc Nephrol; 1997 Nov; 8(11):1788-94. PubMed ID: 9355083
[TBL] [Abstract][Full Text] [Related]
6. Reemergence of sucrose nephropathy: acute renal failure caused by high-dose intravenous immune globulin therapy.
Zhang R; Szerlip HM
South Med J; 2000 Sep; 93(9):901-4. PubMed ID: 11005352
[TBL] [Abstract][Full Text] [Related]
7. Severe antibody-mediated rejection following IVIG infusion in a kidney transplant recipient with BK-virus nephropathy.
Mainra R; Xu Q; Chibbar R; Hassan A; Shoker A
Transpl Immunol; 2013 Jun; 28(4):145-7. PubMed ID: 23685054
[TBL] [Abstract][Full Text] [Related]
8. Acute renal failure following immunoglobulin therapy.
Ahsan N; Wiegand LA; Abendroth CS; Manning EC
Am J Nephrol; 1996; 16(6):532-6. PubMed ID: 8955767
[TBL] [Abstract][Full Text] [Related]
9. Acute renal failure in acquired haemophilia following the use of high dose intravenous immunoglobulin.
Laidlaw S; Bainton R; Wilkie M; Makris M
Haemophilia; 1999 Jul; 5(4):270-2. PubMed ID: 10469182
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin induced-nephropathy: a complication of IVIG therapy.
Ahsan N
J Nephrol; 1998; 11(3):157-61. PubMed ID: 9650125
[TBL] [Abstract][Full Text] [Related]
11. Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins: a case-control study.
Moulis G; Sailler L; Sommet A; Lapeyre-Mestre M; Montastruc JL;
Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):314-9. PubMed ID: 21953992
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin and the kidney--a two-edged sword.
Orbach H; Tishler M; Shoenfeld Y
Semin Arthritis Rheum; 2004 Dec; 34(3):593-601. PubMed ID: 15609263
[TBL] [Abstract][Full Text] [Related]
13. Nephrotoxicity of intravenous immunoglobulin.
Levy JB; Pusey CD
QJM; 2000 Nov; 93(11):751-5. PubMed ID: 11077032
[TBL] [Abstract][Full Text] [Related]
14. Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy.
Daphnis E; Stylianou K; Alexandrakis M; Xylouri I; Vardaki E; Stratigis S; Kyriazis J
Nephron Clin Pract; 2007; 106(4):c143-8. PubMed ID: 17596722
[TBL] [Abstract][Full Text] [Related]
15. Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.
Lozeron P; Not A; Theaudin M; Denier C; Masnou P; Sarov M; Adam C; Cauquil C; Adams D
Muscle Nerve; 2016 May; 53(5):683-9. PubMed ID: 26467654
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulins: in-depth review of excipients and acute kidney injury risk.
Dantal J
Am J Nephrol; 2013; 38(4):275-84. PubMed ID: 24051350
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin: adverse effects and safe administration.
Orbach H; Katz U; Sherer Y; Shoenfeld Y
Clin Rev Allergy Immunol; 2005 Dec; 29(3):173-84. PubMed ID: 16391392
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
Ririe MR; Blaylock RC; Morris SE; Jung JY
J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
[TBL] [Abstract][Full Text] [Related]
19. Acute renal failure after administration of intravenous immunoglobulin: review of the literature and case report.
Winward DB; Brophy MT
Pharmacotherapy; 1995; 15(6):765-72. PubMed ID: 8602385
[TBL] [Abstract][Full Text] [Related]
20. Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis.
Hansen-Schmidt S; Silomon J; Keller F
Am J Kidney Dis; 1996 Sep; 28(3):451-3. PubMed ID: 8804246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
